KFI's Tim Conway Jr. Your Update with Dr. Ray Casciari


Dr. Ray talking about Merck says COVID-19 pill cuts risk of death, hospitalization. Flu season and Covid variants.

  • Merck plans to seek emergency authorization for their oral antiviral treatment for Covid, after the medicine showed "compelling results" in clinical trials.
  • The drug, molnupiravir, reduced the risk of hospitalization or death by about 50% for patients with mild or moderate cases of Covid, the company announced Friday.
  • Molnupiravir is given orally and works by inhibiting the replication of the coronavirus inside the body, according to Merck.
  • If authorized, molnupiravir could be the first oral antiviral medicine for COVID-19.
  • Antiviral treatments currently in use, such as remdesivir, are administered intravenously. 

Dr. Ray has all the answers! Take a listen.

Photo Credit: Getty Images


Sponsored Content

Sponsored Content